Description
Volitinib is an inhibitor of c-Met. It shows antitumor potential in models of gastric cancer. It is being investigated as a treatment for papillary renal cell carcinoma, where it has demonstrated an acceptable tolerability profile.
Product Unit Size | Cost | Quantity | Stock |
---|
Volitinib is an inhibitor of c-Met. It shows antitumor potential in models of gastric cancer. It is being investigated as a treatment for papillary renal cell carcinoma, where it has demonstrated an acceptable tolerability profile.
Cas No. | 1313725-88-0 |
---|---|
Purity | ≥98% |
Formula | C17H15N9 |
Formula Wt. | 345.37 |
Chemical Name | Volitinib |
IUPAC Name | 1-[(1S)-1-(Imidazo[1,2-a]pyridin-6-yl)ethyl]-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine |
Synonym | Savolitinib, HMPL 504, HMPL0-504, HMPL504, AZD-6094, AZD 6094, AZD6094 |
Solubility | Insoluble in water. Solubility in DMSO - ~15 mg/mL. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Gavine P., Ren Y., et al. Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models. Mol Oncol. 9(1):323-33 (2015). PMID: 25248999.
Gan H., Millward M., et al. First-in-Human Phase I Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics and Anti-Tumor Activity. Clin Cancer Res. 2019. PMID: 30952639.
Steroidal jerveratrum alkaloid found in Veratru...
Endogenous peptide, involved in vascular contra...
Mycotoxin produced by Aspergillus; actin polyme...
Adenosine A2A agonist.
Flavonoid found in Epimedium.
Stearoyl-coA desaturase 1 inhibitor.
Endogenous peptide, involved in paracrine and a...
Statin; HMG-CoA reductase inhibitor.
Synthetic progestogen; PR agonist.
Heterocyclic light-emitting compound, natural l...
Loop diuretic; NKCC symporter and HSP90 inhibit...
AurKB/C inhibitor.
Polypeptide; peptidoglycan inhibitor.
Thiol prodrug, antioxidant.
Endogenous peptide involved in vascular contrac...
p110δ PI3K inhibitor.
Dihydropyridine, FIASMA; L-type Ca2+ channel bl...
Abl inhibitor.
Synthetic steroid hormone; ER antagonist.
NET and SERT inhibitor, NMDA antagonist.